The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...
Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...
Axial Spondyloarthritis (axSpA) is a form of arthritis that mainly causes discomfort and inflammation in the spine and ...
ESMO: GSK's Zejula misses survival goal in first-line ovarian cancer, as pharma&'s combo disappoints
In a rough day for PARP inhibitors in ovarian cancer, GSK’s Zejula didn’t deliver a life extension benefit in the final ...
The chance that a patient on the popular ADHD drug will have a psychotic or manic episode on even high doses remained quite ...
Pharmaceutical groups GSK and AstraZeneca are vying to be the first to finally upgrade their popular inhalers which deliver a life-saving puff of medicine but damage the planet.
DelveInsight's Nontuberculous Mycobacterial Infection Market Insights report includes a comprehensive understanding of ...
"Given the unmet medical need and burden associated with genital herpes, innovation in this area is still needed. GSK intends to evaluate the totality of all these data and other studies to progress ...
13d
DelveInsight's Pharmaceutical Excipients Market Insights report provides the current and forecast market analysis, individual ...
Future Market Insights (FMI), a leading authority in pharmaceutical industry analysis, is strategically positioning itself to ...
Shukra Pharmaceuticals Ltd share price was down by -3.01% from ... Glenmark Pharmaceuticals Ltd, Glaxosmithkline Pharmaceuticals Ltd, Biocon Ltd, Ajanta Pharma Ltd, Ipca Laboratories Ltd. Who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback